The influence of immunology and genetics on lymphoma classification: A historical perspective

Cancer Investigation

Volumn 14, Issue 6, 1996, Pages 572-588

  Sreenan, Joseph J ^a   Tubbs, Raymond R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; GENOTYPE; HUMAN; IMMUNOPHENOTYPING; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW;

EID: 0030464785     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909609076902     Document Type: Review

References (164)

1. Falzon M, Issacson PG: Histological classification of the non-Hodgkin's lymphoroa. Blood Rev 4:111-115, 1990.
2. Mann RB, Jaffe ES, Berard CW: Malignant lymphomas - A conceptual understanding of morphologic diversity: A review. Am J Pathol 94(1):105-176, 1979.
3. Rappaport H: Tumors of the hematopoietic system. In: Atlas of Tumor Pathology, Section 3, Fascicle 8, pp 9-14. Washington DC, Armed Forces Institute of Pathology, 1966.
4. Nathwani BN: A critical analysis of the classifications of non-Hodgkin's lymphomas. Cancer 44:347-384, 1979.
5. Isaacson PG: Recent advances in the biology of lymphomas. Eur J Cancer 27:795-802, 1991.
6. Aisenberg AC: Current concepts in immunology: Cell surface markers in lymphoproliferative disease. N Engl J Med 304:331-336, 1981.
7. Hansen JA, Good RA: Malignant disease of the lymphoid system in immunological perspective. Hum Pathol 5(5):567-599, 1974.
8. Stein H, Lennert K, Feller AC, Mason DY: Immunohistological analysis of human lymphoma: Correlation of histological and immunological categories. Adv Cancer Res 42:67-147, 1984.
9. Lukes RJ, Taylor CR, Chir B, et al: A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Am J Pathol 90:461-480, 1978.
10. Collins RD, Lukes RJ: Studies on possible derivation of some malignant lymphomas from follicular center cells. Am J Pathol 62:63a, 1971 (abstract).
11. Lukes RJ, Parker JW, Taylor CR, et al: Immunologic approach to non-Hodgkin lymphomas and related leukemias: Analysis of the results of multiparameter studies of 425 cases. Semin Hematol 15:322-351, 1978.
12. Dorfman RF: Classification of non-Hodgkin's lymphomas. Lancet 1:1295-1296, 1974.
13. Bennett MH, Farrer-Brown G, Henry K, et al: Classification of non-Hodgkin's lymphomas. Lancet 2:405-406, 1974.
14. Mathe G, Rappaport H, O'Conor GT, Torlini H: Histological and cytological typing of neoplastic diseases of hemalopoictic and lymphoid tissues. In: WHO International Histological Classification of Tumors. No. 14.Geneva, World Health Organization, 1976.
15. Higby DJ: A practical classification of lymphomas. N Engl J Med 300(12):283, 1979.
16. Parker JW: Immunologic basis for the redefinition of malignant lymphomas. Am J Clin Pathol 72(4):670-686, 1979.
17. Taylor CR, Chir B, Phil D: Classification of lyinphoma: New thinking on old thoughts. Arch Pathol Lab Med 102:549-554, 1978.
18. Nathwani BN, Hun K, Rappaport H, et al: Non-Hodgkin's lymphomas: A clinicopathologic study comparing two classifications. Cancer 41:303-315, 1978.
19. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage: The non-Hodgkin's lymphoma pathologic classification project. Cancer 49:2112-2135, 1982.
20. Tubbs RR, Sheibani K, Weiss RA, Sebek BA: Immunohisiochemistry of fresh frozen lymphoid tissue with the direct immunoperoxidase technic. Am J Clin Pathol 75:172-174, 1981.
21. Hoffman-Fezer G, Rodt H, Eulitz M, et al: Immunohistochemical identification of T and B lymphocytes delineated by the unlabeted antibody enzyme method. I. Anatomical distribution of theta+ and Ig+cells in lymphoid organs of mice. J Immunol Meth 13:261-270, 1976.
22. Warlike R, Levy R: Immunopathology of follicular lymphomas: A model of B-lymphocyte homing. N Engl J Med 298:481-486, 1978.
23. Tubbs R, Sheibani K, Sebek B, Weiss R: Immunohistochemistry vs immunofluorescence for non-Hodgkin's lymphomas. Am J Clin Pathol 73:144, 1980 (letter).
24. Tubbs RR, Sheibani K, Weiss RA, et al: Tissue immunomicroscopic evaluation of monoclonality of B cell lymphomas: Comparison with cell suspension studies. Am J Clin Pathol 76:24-28, 1981.
25. Tubbs RR, Sheibani K, Deodhar SD: Enzyme immunohistochemistry: Review of technical aspects and diagnostic applications. Cleve Clin Q 48(2):245-281, 1981.
26. Tubbs RR, Fishleder A, Weiss RA, et al: Immunohistologic study of lymphoproliferative disorders: Evaluation of 564 cases, including 267 classified by the International Working Formulation. Am J Pathol 113:207-221, 1983.
27. Sheibani K, Tubbs RR: Enzyme immunohistochemistry: Technical aspects. Semin Diagn Pathol 1:235-250, 1984.
28. Warnke R, Pederson M, Willliams C, Levy R: A study of lymphoproliferative diseases comparing immunofluorescence with immunohistochemistry. Am J Clin Pathol 70:867-875, 1978.
29. Grogan TM, Tubbs RR: A double-blind comparative immunotypic study between two institutions phenotyping non-Hodgkin's lymphomas. Am J Clin Pathol 87:478-484, 1987.
30. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497, 1975.
31. Hsu SM, Raine L, Fanger H: A comparative study of the PAP method and avidin-biotin-complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75:734-738, 1981.
32. Keller RH, Milson TJ, Janicek KM, Patrick CW: Monoclonal antibodies: Clinical utility and the misunderstood epitope. Lab Med 15(12):795-801, 1984.
33. Knowles DM: Immunophenotypic and immunogenotypic approaches useful in distinguishing benign and malignant lymphoid proliferations. Semin Oncol 29(6):583-610, 1993.
34. Tubbs RR, Sheibani K: Immunohistology of lymphoproliferative disorders. Semin Diagn Pathol 1:272-284, 1984.
35. Picker LJ, Weiss LM, Medeiros LJ, et al: Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. Am J Pathol 128:181-201, 1987.
36. Grogan TM, Miller TP: New biologic markers in non-Hodgkin's lymphomas. Hematol Oncol Clin North Am 5(5):925-933, 1991.
37. Grogan TM, Lippman SM, Spier CM, et al: Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 71(4): 1157-1160, 1988.
38. Miller TP, Grogan TM, Dahlberg S, et al: Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial. Blood 83(6): 1460-1466, 1994.
39. Segal G, Stoler M, Fishleder A, Tubbs R: Reliable and cost-effective paraffin section immunohistology of lymphoproliferative disorders. Am J Surg Pathol 15:1034-1041, 1991.
40. Gelb AB, Rouse RV, Dorfman RF, Warnke RA: Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas. Am J Clin Pathol 102:825-834, 1994.
41. Parker JW: Flow cytometric analysis of lymphoproliferative disorders using monoclonal antibodies. Lab Med 16(1):21-31, 1985.
42. Patrick CW, Milson TJ, McFadden PW, Keller RH: Flow cytometry and cell sorting. Lab Med 15(11):740-745, 1984.
43. Parker JW: Flow cytometry in the diagnosis in hematologic diseases. Ann Clin Lab Sci 16(6):427-442, 1986.
44. Parks DR, Hardy RR, Herzenberg LA: Dual immunofluorescence - New frontiers in cell analysis and sorting. Immunol Today 4(5): 145-150, 1983.
45. Braylan RC, Benson NA: Flow cytometric analysis of lymphomas. Arch Pathol Lab Med 113:627-633, 1989.
46. Segal GH, Edinger M, Owen M, et al: Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLADR on lymphoid proliferations using three color immunocytometry. Cytometry 12:350-359, 1991.
47. Diaz J, Edinger M, Stoler M, Tubbs R: Host tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. Leukemia Lymphoma 9:85-90, 1993.
48. Diaz J, Tubbs R, Stoler M, et al: Cylolytic (TIA-1+) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas. Leukemia Lymphoma 9:85-90, 1993.
49. Witzig TE, Banks PM, Stenson MJ, et al: Rapid immunotyping of B-cell non-Hodgkin's lymphomas by How cytometry: A comparison with the standard frozen section method. Am J Clin Pathol 94:280-286, 1990.
50. Borst J, Brouns GS, DeVries E, et al: Antigen receptors on T and B lymphocytes: Parallels in organization and function. Immunol Rev 132:49-84, 1993.
51. Seemayer TA, Cavenee WK: Biology of disease: Molecular mechanisms of oncogenesis. Lab Invest 60(5):585-599, 1989.
52. Cossman J, Uppenkamp M, Sundeen J, et al: Molecular genetics and the diagnosis of lymphoma. Arch Pathol Lab Med 112:117-127, 1988.
53. Katzin WE, Linden MD, Fishleder AJ, Tubbs RR: Immunophenotypic and genotypic characterization of diffuse mixed non-Hodgkin's lymphomas. Am J Pathol 135:615-621, 1989.
54. Medeiros LJ, Bagg A, Cossman J: Molecular genetics in the diagnosis and classification of lymphoid neoplasias, pp 48-97. In: Surgical Pathology of the Lymph Nodes and Related Organs, Vol 16, in Major Problems in Pathology, 2nd ed. Philadelphia, WB Saunders, 1995.
55. Magrath I, Barriga F, McManaway M, Shiramizu B: The molecular analysis of chromosomal translocations as a diagnostic, epidemiological and potentially prognostic tool in lymphoid neoplasia. J Virol Meth 21:275-289, 1988.
56. Sklar JL, Weiss LM, Cleary ML: Diagnostic molecular biology of non-Hodgkin's lymphomas. Monogr Pathol 29:204-224, 1987.
57. Segal G, Wittwer C, Fishleder A, et al: Identification of monoclonal B cell populations by rapid cycle polymerase chain reaction: A practical screening method for the detection of immunoglobulin gene rearrangements. Am J Pathol 141:1291-1297, 1992.
58. Segal GH, Jorgensen T, Scott M: Optimal primer selection for clonality assessment by polymerase chain reaction analysis. II. Follicular lymphomas. Hum Pathol 25:1276-1282, 1994.
59. Segal GH, Jorgensen T, Masih AS, et al: Optimal primer selection for clonality assessment by polymerase chain reaction analysis. 1. Low grade B cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol 25:1269-1275, 1994.
60. Segal GH, Shick HE, Tubbs RR, et al: In situ hybridization analysis of lymphoproliferative disorders: Assessment of clonality of immunoglobulin light chain messenger RNA expression. Diagn Mol Pathol 3(3): 170-177, 1994.
61. Grody WW, Cheng L, Lewin KJ: Application of in situ DNA hybridization technology to diagnostic surgical pathology. Pathol Ann 22(Pt 2):151-175, 1987.
62. Gaffey MJ, Weiss LM: Association of Epstein-Barr virus with human neoplasia. Pathol Ann 27(Pt 1):55-74, 1992.
63. Anastasi J: Interphase cytogenetic analysis in the diagnosis and study of neoplastic disorders. Am J Clin Pathol 95 (Suppl 1):S22-S28, 1991.
64. Harris NL: Lymphoma 1987: An interim approach to diagnosis and classification. Pathol Ann 22(Pt 2):1-67, 1987.
65. Harris NL, Jaffe ES, Stein H, et al: A revised European-American Classification of Lymphoid Neoplasms: A proposal from the International Lymphoma Study Group. Blood 84(5): 1361-1392, 1994.
66. Sander CA, Jaffe ES, Gebhardt FC, et al: Mediastinal lymphoblastic lymphomas with an immature B cell immunophenotype. Am J Surg Pathol 16(3):300-305, 1992.
67. Buccheri V, Mihaljevic B, Matutes E, et al: mb-1: A new marker for B-lineage lymphoblastic leukemia. Blood 82(3):853-857, 1993.
68. Cossman J, Chused TM, Fisher RI, et al: Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 43:4486-4490, 1983.
69. Warnke RA, Link MP: Identification and significance of cell markers in leukemia and lymphoma. Ann Rev Med 34:117-131, 1983.
70. Flug F, Dodson L, Wolff J, et al: B-lymphocyte associated differentiation antigen expression by non-B, non-T, acute lymphoblastic leukemia. Leuk Res 9(8):1051-1058, 1985.
71. Tubbs RR, Fishleder A, Weiss RA, et al: Immunohislologic cellular phenotypes of lymphoproliferative disorders: Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation. Am J Pathol 113:207-221, 1983.
72. Sunoeen JT, Longo DL, Jaffe ES: CD5 expression in B cell small lymphocytic malignancies: Correlations with clinical presentation and sites of disease. Am J Surg Pathol 16(2): 130-137, 1992.
73. Harris ML, Bhan AK: B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: Immunohistologic analysis and clinical correlation. Hum Pathol 16:829-837, 1985.
74. Almasri NM, Duque RE, Iturraspe J, et al: Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 40:259-263, 1992.
75. Spier CM, Grogan TM, Fielder K, et al: Immunophenotypes in well-differenlialed lymphoproliferative disorders with emphasis on small lymphocytic lymphoma. Hum Pathol 17:1126-1136, 1986.
76. Sheibani K, Nathwani BN, Winberg CD, et al: Small lymphocylic lymphoma: Morphologic and immunologic progression. Am J Clin Pathol 84:237-243, 1985.
77. Strickler JG, Medeiros J, Copenhaver CM, et al: Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Hum Pathol 19:550-554, 1988.
78. Zukerberg LR, Medeiros JL, Ferry JA, Harris NL: Diffuse low-grade B-cell lymphomas - Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol 100:373-385, 1993.
79. Dorfman DM, Pinkus GS: Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Mod Pathol 7(3):326-331, 1994.
80. Segal G, Stoler M, Tubbs R: The CD43 only phenotype: An aberrant, nonspecific immunophenotype requiring comprehensive analysis for lineage resolution. Am J Clin Pathol 97:861-865, 1992.
81. Fisher RI, Dahlberg S, Nathwani BN, et al: A clinical analysis of two indolent lymphoma entities: Mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): A Southwest Oncology Group Study. Blood 85(4):1075-1082, 1995.
82. Lardelli P, Bookman MA, Sundeen J, et al: Lymphocytic lymphoma of intermediate differentiation: Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 14(8):752-763, 1990.
83. Samoszuk MK, Epstein AL, Said J, et al: Sensitivity and specificity of immunostaining in the diagnosis of mantle zone lymphoma. Am J Clin Pathol 85:557-563, 1986.
84. Ellison DJ, Turner RR, Antwerp RV, et al: High grade mantle zone lymphoma. Cancer 60:2717-2720, 1987.
85. Frizzera G, Sakurai M, Notohara K, Konishi H: t(11;14)(q13;q32) in B cell lymphomas (intermediately differentiated lymphocytic and follicular): A report of four cases. Am J Clin Pathol 95:684-691, 1991.
86. Bosch F, Jares P, Campo E, et al: PRAD-1/Cyclin D1 gene over-expression in chronic lymphoproliferative disorders: A highly specific marker of mantle cell lymphoma. Blood 84(8):2726-2732, 1994.
87. Grogan TM, Hicks MJ, Jolley CS, et al: Identification of two major B cell forms of nodular mixed lymphoma. Lab Invest 51(5):504-514, 1984.
88. Weiss LM, Warnke RA: Follicular lymphoma with blastic conversion: A report of two cases with confirmation by immunoperoxidase studies on bone marrow sections. Am J Clin Pathol 83:681-686, 1985.
89. Gaulard P, d'Agay MF, Pejchmaur M, et al: Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol 140(5): 1089-1095, 1992.
90. Shibata D, Hu E, Weiss LM, et al: Detection of specific t(14;18) chromosomal translocations in fixed tissues. Hum Pathol 21:199-203, 1990.
91. Harris ML: Extranodal lymphoid infiltrates and mucosa-associated lymphoid tissue (MALT) - A unifying concept. Am J Surg Pathol 15(9):879-884, 1991.
92. Schmid C, Kirkham N, Diss T, Isaacson PG: Splenic marginal zone cell lymphoma. Am J Surg Pathol 16(5):455-466, 1992.
93. Ngan BY, Warnke RA, Wilson M, et al: Monocytoid B cell lymphoma: A study of 36 cases. Hum Pathol 22:409-421, 1991.
94. Sheibani K, Ben-Ezra J, Swartz WG, et al: Monocytoid B-cell lymphoma in a patient with human immunodeficiency virus infection. Arch Pathol Lab Med 114:1264-1267, 1990.
95. Shin SS, Sheibani K: Monocytoid B-cell lymphoma. Am J Clin Pathol 99(4):421-425, 1993.
96. Mollejo M, Menarguez J, Crislobal E, et al: Monocytoid B cells - A comparative clinical pathological study of their distribution in different types of low grade lymphomas. Am J Surg Pathol 18(11): 1131-1139, 1994.
97. Isaacson PG, Spencer J: Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology 11:445-462, 1987.
98. Stroup R, Sheibani K: Antigenic phenotypes of hairy cell leukemia and monocytoid B-cell lymphoma: An immunohistochemical evaluation of 66 cases. Hum Pathol 23:172-177, 1992.
99. Wotherspoon AC, Diss TC, Pan LX, et al: Primary low-grade B-cell lymphoma of the conjunctiva: A mucosa-associated lymphoid tissue type lymphoma. Histopathology 23:417-424, 1993.
100. Melo JV, Hegde U, Parreira A, et al: Splenic B cell lymphoma with circulating villous lymphocytes: Differential diagnosis of B cell leukaemias with large spleens. J Clin Pathol 40:642-651, 1987.
101. Tubbs RR, Savage RA, Fishleder A, et al: Antigenic phenotype of splenic hairy cells. Am J Med 76:199-205, 1984.
102. Hsu SM, Yang K, Jaffe ES: Hairy cell leukemia: A B cell neoplasm with a unique antigenic phenotype. Am J Clin Pathol 80:421-428, 1983.
103. Miller ML, Fishleder AJ, Tubbs RR: The expression of CD22 (Leu 14) and CD11c (LeuM5) in chronic lymphoproliferative disorders using two-color flow cytometric analysis. Am J Clin Pathol 96:100-108, 1991.
104. Falini B, Schwarting R, Erber W, et al: The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. Am J Clin Pathol 83:289-300, 1985.
105. Moller P, Mielke B, Moldenhauer G: Monoclonal antibody HML-1, a marker for intraepithelial T cells and lymphomas derived therof, also recognizes hairy cell leukemia and some B cell lymphomas. Am J Pathol 136:509-512, 1990.
106. Linden MD, Fishleder AJ, Tubbs RR, Park H: Immunophenotypic spectrum of plasma cell leukemia. Cancer 63:859-862, 1989.
107. Harada H, Kawano MM, Huang N, et al: Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 81(10): 2658-2663, 1993.
108. Pellat-Deceunynck C, Bataille R, Robillard N, et al: Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood 84(8):2597-2603, 1994.
109. Van Camp B, Durie BGM, Spier C, et al: Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19), Blood 76(2):377-382, 1990.
110. Strickler JG, Audeh MW, Copenhaver CM, Warnke RA: Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma. Cancer 61:1782-1786, 1988.
111. Doggett RS, Wood GS, Horning S, et al: The immunologic characterization of 95 nodal and extranodal diffuse large cell lymphomas in 89 patients. Am J Pathol 115:245-252, 1984.
112. Spier CM, Grogan TM, Lippman SM, et al: The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma. Am J Pathol 133:118-126, 1988.
113. Schneider DR, Taylor CR, Parker JW, et al: Immunoblastic sarcoma of T and B cell types: Morphologic description and comparison. Hum Pathol 16:885-900, 1985.
114. Garcia CF, Weiss LM, Warlike RA: Small noncleaved cell lymphoma: An immunophenotypic study of 18 cases and comparison with large cell lymphoma. Hum Pathol 17:454-461, 1986.
115. Jacobson JO, Wilkes BM, Kwiatkowski DJ, et al: bcl-2 rearrangements in de novo diffuse large cell lymphoma: Association with distinctive clinical features. Cancer 72:231-236, 1993.
116. Lo Coco F, Ye BH, Lista F, et al: Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 83(7): 1757-1759, 1994.
117. Perrone T, Frizzera G, Rosai J: Mediastinal diffuse large cell lymphoma with sclerosis: A clinicopathologic study of 60 cases. Am J Surg Pathol 10(3): 176-191, 1986.
118. Pavlova Z, Parker JW, Taylor CR, et al: Small noncleaved follicular center cell lymphoma: Burkitt's and non-Burkitt's variants in the US. II. Pathologic and immunologic features. Cancer 59:1892-1902, 1987.
119. Aisenberg AC: New genetics of Burkitt's lymphonia and other non-Hodgkin's lymphomas. Am J Med 77:1083-1089, 1984.
120. Brownell MD, Sheibani K, Battifora H, et al: Distinction between undifferentiated (small noncleaved) and lymphoblastic lymphoma: An immunohistologic study on paraffin-embedded, fixed tissue sections. Am J Surg Pathol 11(10):779-787, 1987.
121. Pelicci PC, Knowles DM, Magrath I, et al: Chromosomal break-points and structural alterations of the c-myc locus differ inendemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 83:2984-2988 1986.
122. Neri A, Barriga F, Knowles DM, et al: Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 85:2748-2752, 1988.
123. Weiss LM, Bindl JM, Picozzi VJ, et al: Lymphoblastic lymphoma: An immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 67(2):474-478, 1986.
124. Knowles DM: The human T cell leukemias: Clinical, cytomorphologic, immunophenotypic and genotypic characteristics. Hum Pathol 17:14-33, 1986.
125. Riopel M, Dickman PS, Link MP, Perlman EJ: MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 25:396-399, 1994.
126. mic2) Neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker: Review of more than 600 tumors and the literature experience. Appl Immunohistochem 2(4):231-240, 1994.
127. Cabecadas JM, Isaacson PG: Phenotyping of T cell lymphomas in paraffin sections - Which antibodies? Histopathology 19:419-424, 1991.
128. Knowles DM, Pelicci PC, Dalla-Favera R: T cell receptor beta chain gene rearrangements: Genetic markers of T cell lineage and clonality. Hum Pathol 17(6):546-551, 1986.
129. Matutes E, Brito-Babapulle V, Swansbury J, et al: Clinical and laboratory featrues of 78 cases of T-prolymphocytic leukemia. Blood 78(12):3269-3274, 1991.
130. Foa R, Pelicci PG, Migone N, et al: Analysis of T cell receptor beta chain (Tβ) gene rearrangements demonstrates the monoclonal nature of T cell chronic lymphoproliferative disorders. Blood 67(1): 247-250, 1986.
131. Suchi T, Lennert K, Tu LY, et al: Histopathology and immunohistochemistry of peripheral T cell lymphomas: A proposal for their classification J Clin Pathol 40:995-1015, 1987.
132. Loughran Jr TP: Clonal diseases of large granular lymphocytes. Blood 82(1):1-14, 1993.
133. Tefferi A, Li C-Y, Witzig TE, et al: Chronic natural killer cell lymphocytosis: A descriptive clinical study. Blood 84(8):2721-2725, 1994.
134. Kwong YL, Wong KF, Chan LC, et al: Large granular lymphocyte leukemia - A study of nine cases in a Chinese population. Am J Clin Pathol 103:76-81, 1995.
135. Rambaldi A, Pelicci PG, Allavena P, et al: T cell receptor β chain gene rearrangements in lymphoproliferative disorders of large granular lymphocytes/natural killer cells. J Exp Med 162:2156-2162, 1985.
136. + aggressive variant of large granular lymphocyte leukemia. Blood 84(7): 2315-2321, 1994.
137. Pelicci PG, Allavena P, Subar M, et al: T cell receptor (α, β, β) gene rearrangements and expression in normal and leukemic large granular lymphocytes/natural killer cells. Blood 70(5):1500-1508, 1987.
138. Wood GS, Abel EA, Hoppe RT, et al: Leu-8 and Leu-9 antigen phenotypes: Immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. J Am Acad Dermatol 14:1006-1013, 1986.
139. Ralfkiaer E, O'Connor NTJ, Crick J, et al: Genotypic analysis of cutaneous T cell lymphomas. J Invest Dermatol 88:762-765, 1987.
140. Abel EA, Wood GS, Hoppe RT, et al: Expression of Leu-8 antigen, a majority T cell marker, is uncommon in mycosis fungoides. J Invest Dermatol 85:199-202, 1985.
141. Ralfkiaer E, Wantzin GL, Mason DY, et al: Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Am J Clin Pathol 84:610-619, 1985.
142. Winberg CD: Peripheral T cell lymphoma: Morphologic and immunologic observations. Hum Pathol 99(4):426-435, 1993.
143. Pinkus GS, O'Hara CJ, Said JW: Peripheral/post-thymic T cell lymphomas: A spectrum of disease-Clinical, pathologic, and immunologic features of 78 cases. Cancer 65:971-998, 1990.
144. Weiss LM, Crabtree GS, Rouse RV, et al: Morphologic and immunologic characterization of 50 peripheral T cell lymphomas. Am J Pathol 118:316-324, 1985.
145. Grogan TM, Fielder K, Rangel C, et al: Peripheral T cell lymphoma: Aggressive disease with heterogeneous immunotypes. Am J Clin Pathol 83:279-288, 1985.
146. Borowitz MJ, Reichert TA, Brynes RK, et al: The phenotypic diversity of peripheral T cell lymphomas: The Southeastern Cancer Study Group experience. Hum Pathol 17:567-574, 1986.
147. Weis JW, Winter MW, Phyliky RL, et al: Peripheral T cell lymphomas: Histologic, immunohistologic, and clinical characterization. Mayo Clin Proc 61:411-426, 1986.
148. Strickler JG, Weiss LM, Copenhaver CM, et al: Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T cell lymphomas. Hum Pathol 18:808-814, 1987.
149. Weiss LM, Picker LJ, Grogan TM, et al: Absence of clonal beta and gamma T cell receptor gene rearrangements in a subset of peripheral T cell lymphomas. Am J Pathol 130:436-442, 1988.
150. Weiss LM, Strickler JG, Dorfman RF, et al: Clonal T cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol 122: 392-397, 1986.
151. Lipford EH, Margolick JB, Longo DL, et al: Angiocentric immunoproliferative lesions: A clinicopathologic spectrum of post-thymic T cell proliferations. Blood 72(5):1674-1681, 1988.
152. Spencer J, Cerf-Bensussan N, Jarry A, et al: Enteropathy-associated T cell lymphoma (malignant histiocytosis of the intestine) is recognized by a monoclonal antibody (HML-1) that defines a membrane molecule on human mucosal lymphocytes. Am J Pathol 132:1-5, 1988.
153. Spencer J, MacDonald TT, Diss TC, et al: Changes in intraepithelial lymphocyte subpopulations in coeliac disease and enteropathy associated T cell lymphoma (malignant histiocytosis of the intestine). Gut 30:339-346, 1989.
154. Wolf BC, Martin AW, Ree HJ, et al: Non-Hodgkin's lymphomas of the gastrointestinal tract: An evaluation of paraffin section immunostaining. Am J Clin Pathol 93:233-239, 1990.
155. Jaffe ES, Clark J, Steis R: Lymph node pathology of HTLV and HTLV-associated neoplasms. Cancer Res 45 (Suppl):4662s-4664s, 1985.
156. Chadburn A, Athan E, Wieczorek R, et al: Detection and characterization of human T cell lymphotropic virus type 1 (HTLV-I) associated T cell neoplasms in an HTLV-I nonendemic region by polymerase chain reaction. Blood 77(11):2419-2430, 1991.
157. Chan KC (Commentary): CD30+(Ki-1) lymphoma: t(2;5) translocation, the implicated genes, and more . . . Adv Anal Pathol 2(2):99-104, 1995. On: Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994.
158. Chan KC (Commentary): CD30+(Ki-1) lymphoma: t(2;5) translocation, the implicated genes, and more . . . Adv Anal Pathol 2(2):99-104, 1995. On: Morris SW, Kirstein MN, Valentine MB, et al: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281-1284, 1994.
159. + T cell lymphoma. Am J Surg Pathol 17(9):859-868, 1993.
160. Kinney MC, Glick AD, Stein H, et al: Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features. Am J Surg Pathol 14(11): 1047-1060, 1990.
161. Agnarsson BA, Kadin ME: Ki-1 positive large cell lymphoma - A morphologic and immunologic study of 19 cases. Am J Surg Pathol 12(4):264-274, 1988.
162. Rimokh R, Magaud JP, Berger F, et al: A translocation involving a specific breakpoint (q35) on chromosome 5 is characteristic of anaplastic large cell lymphoma (Ki-1 lymphoma). Br J Hematol 71:31-36, 1989.
163. Herbst H, Tippelmann G, Anagnostopoulos I, et al: Immunoglobulin and T cell receptor gene rearrangements in Hodgkin's disease and Ki-1 positive anaplastic large cell lymphoma: Dissociation between phenotype and genotype. Leuk Res 13(2):103-116, 1989.
164. Fischer P, Nacheva E, Mason DY, et al: A Ki-1 (CD30) positive human cell line (Karpas 299) established from a high grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T cell receptor β-chain gene. Blood 72(1):234-240, 1988.